ML Draft Summits

Patient Advocacy and Expert Summits

Regional and International Summits

Convening patients, advocates, and experts for improved treatments and outcomes

The Angiogenesis Foundation holds summits around the world to bring together patients, advocates, and leading experts in disease areas impacted by angiogenesis. Stakeholders address important topics ranging from improving patients’ access to and awareness of angiogenesis-based treatments, to the current care pathways for disease, to the future of disease treatment. Summit white papers crystalize the issues, challenges, and recommendations for optimizing anti-angiogenic therapies to improve treatment outcomes.


2017 National Expert Summit: Improving Long-Term Treatment Outcomes in Age-Related Macular Degeneration 

In August 2017, the Angiogenesis Foundation convened leading retina specialists, patients, caregivers and vision advocates to discuss the need to improve long-term outcomes for people living with neovascular age-related macular degeneration (AMD). The participants gave recommendations for improving treatment pathways for AMD and discussed solutions for better long-term patient outcomes.

2015 National Summit on Diabetic Vision Loss 

In June 2015, the Angiogenesis Foundation convened an expert summit in Washington, D.C., to discuss the health care burden of diabetic vision loss, and the current challenges and opportunities in the care pathway for diabetic eye diseases.

2015 Canadian National Summit on Diabetic Macular Edema (DME)

In January 2015, the Angiogenesis Foundation hosted a summit in Toronto, Canada, convening international leaders in DME treatment and translational science to discuss the global challenges regarding the prevention, diagnosis, and treatment of DME.

2014 Paris International Summit on Diabetic Macular Edema (DME) 

In June 2014, the Foundation brought together leading experts to discuss improved awareness and early detection of DME, as well as improved treatments and patient outcomes. The meeting was held in Paris, France, inside the Eiffel Tower.

2013 Berlin International Summit on Age-Related Macular Degeneration (AMD)

Experts met at the Berlin Marriott Hotel in Berlin to discuss improved awareness and early detection of wet age-related macular degeneration as well as solutions for improved treatments and outcomes for people living with wet AMD.

2013 Asia-Pacific Summit on Age-Related Macular Degeneration (AMD)

In February 2013, leaders convened in Hong Kong for interactive, moderated roundtable discussions about the treatment and management of wet AMD among Asia-Pacific populations. Experts developed a research agenda specific to the Asia-Pacific region that could move the field toward the desired future state of AMD prevention, diagnosis, and treatment. 

2012 Australia Summit on Age-Related Macular Degeneration

In Sydney, Australia, the Foundation convened experts in wet age-related macular degeneration (AMD) to discuss ways to improve treatment options and outcomes for people with living with wet AMD.

2012 Latin America Summit on Age-Related Macular Degeneration (AMD)

Experts convened in Bogota, Colombia, to discuss prevention, diagnosis, and treatment of AMD in Latin America. Participants outlined the barriers and steps needed to improve patient outcomes.

2011 Berlin International Summit on Age-Related Macular Degeneration (AMD)

Experts discussed and achieved agreement on the rationale for anti-angiogenic therapy to treat wet AMD; the role of early intervention in preventing wet AMD-associated blindness; the safety of repeated, long-term therapy; and the role of chronic suppressive anti-angiogenic therapy for wet AMD.


 Latin American International Expert
Summit for Metastatic Colorectal Cancer (mCRC)

In 2014, the Angiogenesis Foundation convened an international expert summit to improve patient outcomes in metastatic colorectal cancer (mCRC). The summit, held in Buenos Aires, Argentina, was an interactive roundtable addressing gaps in colorectal cancer research and treatment, with a specific emphasis on Latin American populations.

2013 Berlin Summit on Colorectal Cancer (CRC)

Experts including physicians, patients, advocates, and medical comparative effectiveness researchers met in Berlin for a two-day discussion on improving outcomes in the treatment and management of metastatic colorectal cancer (mCRC).

2013 National Summit on Colorectal Cancer (CRC)

Experts including physicians, nurses, advocates, and medical comparative effectiveness researchers met in Washington, D.C., for a two-day discussion on advancing treatment outcomes for people with metastatic colorectal cancer (mCRC).

Wound Healing

National Multi-Stakeholder Wound

This national multi-stakeholder summit was held outside of Washington, D.C., in October 2015. This interactive roundtable discussion brought together chronic wound experts, patients and advocates. During the summit, participants identified the key gaps in the current care pathway for treating chronic wounds and developed a robust action plan to overcome the barriers and bridge the gaps in wound care for better patient outcomes.

National Wound Healing Expert Summit 

In July 2012, the Angiogenesis Foundation and the American College of Wound Healing and Tissue Repair jointly convened a high-level multi-stakeholder Expert Summit in Chicago to assess recent developments in wound care and to address the outcomes and experiences valued by patients suffering from chronic and delayed healing wounds. The expert summit led to a first-of-its-kind white paper that summarizes the issues, identifies the desired state of the wound care field from a patient perspective, and presents a framework for defining and assessing patient-centered outcomes in chronic wound treatment.

Anti-Angiogenic Therapy

2001 Anti-Angiogenic Therapy Expert Panel 

The Angiogenesis Foundation convened an expert panel for clinical trials of anti-angiogenic therapy in cancer in June 2001, in San Francisco, California. The charge of the panel was to review the data from clinical trials of anti-angiogenic therapy in cancer and make recommendations for improving trial design and optimizing trial outcomes. The deliberations of this panel led to refinements in clinical trial design that are used for cancer drug development to this day.



The Angiogenesis Foundation convened expert panels for clinical trials of coronary angiogenesis, which met in 1999 and 2000 in Atlanta, Georgia and Anaheim, California, respectively. The charge of the panels was to review the data from therapeutic angiogenesis clinical trials and to make recommendations for improving trial design and optimizing trial outcomes. The output was published as a white paper in circulation.

Critical Limb Ischemia (CLI)

CLI Advocacy Summits

The Angiogenesis Foundation convened two advocacy summits for critical limb ischemia (CLI) in 2010. CLI is a condition characterized by chronic ischemic at-rest pain, ulcers, or gangrene in one or both legs attributable to peripheral arterial disease (PAD), and is an area of substantial unmet medical need and active research. To address this global issue, the Angiogenesis Foundation brought together a multidisciplinary group of leading CLI experts from North America and Europe at two conferences held in Crystal City, Virginia (June 2010) and Berlin, Germany (October 2010), respectively. The experts addressed four major issues: the obstacles and challenges for improving outcomes in CLI, generating disease awareness, establishing care pathways, and value analysis/reimbursement.